GGrantIndex
Sort

141,003 grants matching cytokine

Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

$2,569,903
Joren C Madsen · Massachusetts General Hospital · U01 · FY2019 · AI

Targeting checkpoint inhibitors for pain control

$2,569,851
Ru-Rong Ji · Duke University · RF1 · FY2023 · NS

Optimizing HIV prevention for highly vulnerable methamphetamine-using sexual minority men

$2,568,889
Christian Grov · Graduate School Of Public Health And Health Policy · UG3 · FY2023 · AI

Characterization of the cellular and molecular bases of combined immunodeficiencies

$2,566,681
Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Molecular Targeting of Developmental Cancers in Children

$2,564,487
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA

Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation

$2,562,331
Daniel N Streblow · Oregon Health & Science University · P01 · FY2024 · AI

Protection of Ischemic Myocardium

$2,562,122
Roberto Bolli · University Of Louisville · P01 · FY2012 · HL

Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection

$2,560,905
Andrea Goldberg Edlow · Massachusetts General Hospital · RF1 · FY2022 · MH

Metabolic Syndrome, Inflammation and Vascular Remodeling

$2,560,516
Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2007 · HL

Combination Therapies to Defeat Melanoma Resistance

$2,556,789
Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA

Combination Therapies to Defeat Melanoma Resistance

$2,556,789
Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA

SPORE in Genitourinary Cancer

$2,549,962
Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2007 · CA

SPORE IN PROSTATE CANCER

$2,549,885
Baylor College Of Medicine · P50 · FY2000 · CA

Pathogenic Mechanisms in Spondyloarthritis

$2,547,361
Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR

Epigenomic analysis of primary immune cells from young and old animals

$2,546,202
Myong-Hee Sung · National Institute On Aging · ZIA · FY2023 · AG

Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation

$2,545,712
Daniel N Streblow · Oregon Health & Science University · P01 · FY2025 · AI

Asthma Inflammation Research (AIR)

$2,545,423
Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2013 · HL

SPORE in Lymphoma

$2,545,025
Johns Hopkins University · P50 · FY2005 · CA

Precision Medicine of Cancer

$2,545,004
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Cytokine Signaling, Immunoregulation and Autoimmune and Immunodeficiency Diseases

$2,543,374
John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR

PACT

$2,541,917
Adrian Philip Gee · Baylor College Of Medicine · N01 · FY2010 · HL

NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS

$2,540,338
Norman L Letvin · Beth Israel Deaconess Medical Center · N01 · FY2011 · AI

Transfusion and Lung Injury

$2,540,225
Pearl T Toy · University Of California, San Francisco · P50 · FY2009 · HL

PERIODONTAL INTERVENTION FOR CARDIAC EVENTS: PILOT TRIAL

$2,538,337
State University Of New York At Buffalo · U01 · FY2003 · DE

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,537,053
Christopher K Glass · University Of California, San Diego · P01 · FY2020 · HL